Editorial Board Members’ Collection Series: Intensive Care and Anesthesiology

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Intensive Care/ Anesthesiology".

Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 2524

Special Issue Editors


E-Mail Website
Guest Editor
Cátedras de Farmacología Aplicada y Terapia Intensiva, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Argentina y Sanatorio Otamendi, Buenos Aires, Argentina
Interests: oxygen transport; carbon dioxide metabolism; shock; microcirculation; acid-base metabolism

E-Mail Website
Guest Editor
1. University Hospital “San Giovanni di Dio e Ruggi d’Aragona”, 84131 Salerno, Italy
2. Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno, 84084 Fisciano, Italy
Interests: sepsis; trauma; heart and lung failure
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA
Interests: airway management; anesthesia education; anesthesia for general surgery; burn injury; critical care; post-anesthesia care

Special Issue Information

Dear Colleagues,

We are pleased to announce this Special Issue, titled “Editorial Board Members' Collection Series: Intensive Care and Anesthesiology”. This Special Issue will be a collection of papers from our Editorial Board Members and researchers invited by the Editorial Board Members. The aim is to provide a venue for networking and communication between Medicina and scholars in the field of gastrointestinal and hepatic diseases. All papers will be published fully open access after undergoing peer review.

Prof. Dr. Arnaldo Dubin
Prof. Dr. Ornella Piazza
Dr. Edward A. Bittner
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • critical care
  • airway management
  • post-anesthesia care
  • anesthesia for general surgery
  • burn injury
  • microcirculation
  • acid-base metabolism
  • oxygen transport
  • sepsis
  • heart and lung failure
  • trauma
  • emergency medicine
  • acute pain management
  • intra-operative management

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

8 pages, 838 KiB  
Article
Right Axillary Artery Cannulation for Veno-Arterial Extracorporeal Membrane Oxygenation in Postcardiotomy Patients: A Single-Center Experience
by Medhat Radwan, Karim Baghdadi, Aron Frederik Popov, Rodrigo Sandoval Boburg, Petar Risteski, Christian Schlensak, Thomas Walter, Rafal Berger and Fabian Emrich
Medicina 2023, 59(11), 2040; https://doi.org/10.3390/medicina59112040 - 20 Nov 2023
Viewed by 971
Abstract
Background and Objectives: To analyze the patient outcome and complication rate of axillary artery cannulation for veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in patients who could not be weaned from cardiopulmonary bypass after cardiothoracic surgery. Materials and Methods: We analyzed the data of [...] Read more.
Background and Objectives: To analyze the patient outcome and complication rate of axillary artery cannulation for veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in patients who could not be weaned from cardiopulmonary bypass after cardiothoracic surgery. Materials and Methods: We analyzed the data of 179 patients who were supported with VA-ECMO with femoral–axillary access (FA VA-ECMO) after cardiothoracic surgery between January 2014 and January 2019 in our department. Patients requiring central aortic cannulation and patients with respiratory failure requiring veno-venous ECMO were excluded. Primary outcomes were in-hospital mortality and 1-year survival rate of patients who were weaned from VA-ECMO support. Secondary outcomes were cannulation-related complications at the axillary site, VA-ECMO-related complications, and systemic complications. Results: In our cohort, 60 (33.5%) patients were female. Mean age was 67.0 ± 10.9 years. Overall, 78 (43.5%) patients were operated upon electively, 37 (20.7%) patients underwent urgent surgery, and 64 (35.8%) patients underwent emergency surgical treatment. Sixty-seven patients (37.4%) were resuscitated preoperatively. The mean duration of VA-ECMO support was 8.4 ± 5.1 days. Weaning from VA-ECMO was successful in 87 (48.6%) patients; 62 (34.6%) patients survived the hospital stay. The 1-year survival rate was 74%. Subclavian bleeding occurred in 24 (13.4%) patients, femoral bleeding in 4 (2.2%) patients, ischemia of the upper limb in 11 (6.1%) patients, intracerebral bleeding in 9 (5%) patients, and stroke in 19 (10.6%) patients. Conclusions: In patients with acute LV dysfunction after cardiothoracic surgery who cannot be weaned from cardiopulmonary bypass, right axillary artery cannulation is a safe and reliable method for VA-ECMO support with an acceptable complication rate. Full article
Show Figures

Figure 1

Other

Jump to: Research

8 pages, 289 KiB  
Case Report
Remimazolam Anaphylaxis during Induction of General Anesthesia Confirmed by Provocation Test—A Case Report and Literature Review
by Sangho Lee, Joyoung Park, Na Hei Kim, Halin Hong, Kyoung Hee Sohn, Hee Yong Kang, Mi Kyeong Kim and Ann Hee You
Medicina 2023, 59(11), 1915; https://doi.org/10.3390/medicina59111915 - 30 Oct 2023
Viewed by 1229
Abstract
Background: Remimazolam besylate, a newly developed drug, is linked to various anaphylaxis cases. We present a case of remimazolam anaphylaxis confirmed using a provocation test. Case: A 51-year-old female patient was scheduled for humeral pinning. General anesthesia was induced using remimazolam, [...] Read more.
Background: Remimazolam besylate, a newly developed drug, is linked to various anaphylaxis cases. We present a case of remimazolam anaphylaxis confirmed using a provocation test. Case: A 51-year-old female patient was scheduled for humeral pinning. General anesthesia was induced using remimazolam, rocuronium, and remifentanil. After tracheal intubation, the patient experienced decreased blood pressure, increased heart rate, and a systemic rash. Epinephrine was administered repeatedly, and the patient’s vital signs stabilized. Acute phase tryptase levels were within normal limits. After four weeks, intradermal test results were negative. When remimazolam was administered intravenously for the provocation test, facial swelling, flushing, and coughing occurred, which improved with epinephrine. The culprit drug was identified as remimazolam using a provocation test. Conclusions: When anaphylaxis occurs during anesthesia induction, remimazolam should not be ruled out as the causative drug. If the skin test result for remimazolam is negative, a provocation test should be considered. The provocation test should be initiated cautiously at a low dose under careful patient monitoring. Full article
Back to TopTop